Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Adtalem's RUSM Partners With CSUDH, Boosts Physician Diversity

Published 09/10/2019, 11:10 PM
Updated 07/09/2023, 06:31 AM

Adtalem Global Education Inc.’s (NYSE:ATGE) health care institution, Ross University School of Medicine (“RUSM”), has partnered with California State University, Dominguez Hills (“CSUDH”), to enable Hispanic students attend medical school. Notably, this will also increase the Hispanic-American doctors in the United States.

Per the terms of the agreement, the partnership will also provide an educational pathway program for CSUDH’s graduates to study medicine at RUSM. Eligible graduates will receive a scholarship for the first semester covering full tuition in the RUSM campus in Barbados.

Adtalem’s Endeavors to Address Diversity in Medicine

RUSM — one of the medical and veterinary schools of Adtalem — has a diverse student population, of which, more than one-fourth of the total students are Hispanic. Of the total U.S. physicians, Hispanic Americans account for only 5%.

RUSM remains well positioned to address the paucity of Hispanic and Latinx physicians, and the significant roles they play in the healthcare industry. Notably, due to the changing demographics in the overall healthcare in United States and the underrepresentation of culturally different people in healthcare, RUSM has partnered with Hispanic Serving Institution and Historically Black Colleges and Universities through novel student engagements, support programs and senior-level commitments. This will help increase the diversity of the nation’s physicians.

Notably, in the fiscal fourth quarter, revenues at the Medical and Healthcare segment grew 5.2 % year over year. This uptick was driven by a 6.9% and a 3% increase in revenues at Chamberlain and Medical and Veterinary schools, respectively.

Price Performance

In a year’s time, shares of Adtalem have declined 8.3% against its industry’s 24.4% growth. However, the above-mentioned initiatives are expected to aid the company’s revenues and profitability going forward.



In particular, Adtalem’s health care and international institutions have shown significant improvement in recent times. Overall, initiatives for achieving strong multi-year organic growth, cost-saving initiatives and transformation strategy should drive growth.

Zacks Rank & Key Picks

Currently, Adtalem carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the same industry include K12, Inc. (NYSE:LRN) , Lincoln Educational Services Corporation (NASDAQ:LINC) and Bright Horizons Family Solutions Inc. (NYSE:BFAM) . While K12 and Lincoln sport a Zacks Rank #1 (Strong Buy), Bright Horizons carries a Zacks Rank #2 (Buy). You can the complete list of today’s Zacks #1 Rank stocks here.

K12, Lincoln and Bright Horizons have an impressive long-term earnings growth rate of 15%,15% and 10.1%, respectively.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



K12 Inc (LRN): Free Stock Analysis Report

Bright Horizons Family Solutions Inc. (BFAM): Free Stock Analysis Report

Lincoln Educational Services Corporation (LINC): Free Stock Analysis Report

Adtalem Global Education Inc. (ATGE): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.